Edition:
United Kingdom

Alligator Bioscience AB (ATORX.ST)

ATORX.ST on Stockholm Stock Exchange

24.80SEK
9:40am GMT
Change (% chg)

-0.20kr (-0.80%)
Prev Close
25.00kr
Open
25.95kr
Day's High
25.95kr
Day's Low
24.55kr
Volume
27,305
Avg. Vol
72,404
52-wk High
39.00kr
52-wk Low
22.10kr

Latest Key Developments (Source: Significant Developments)

Alligator Bioscience Will Receive $3.5 Mln Under Agreement With Abclon
Wednesday, 7 Nov 2018 

Nov 7 (Reuters) - Alligator Bioscience AB ::ALLIGATOR BIOSCIENCE TO RECEIVE MILLION-DOLLAR PAYMENTS - ABCLON PARTNER EXERCISES OPTION.WILL RECEIVE PAYMENTS OF MORE THAN USD 3.5 MILLION UNDER ITS COLLABORATION AGREEMENT WITH SOUTH KOREAN COMPANY ABCLON.PAYMENTS FOLLOWING EXERCISING OF AN OPTION BY HENLIUS , TO EXPAND FROM A REGIONAL TO A GLOBAL AGREEMENT.  Full Article

Alligator Bioscience Q3 Net Sales Sek 0.2 Million
Friday, 26 Oct 2018 

Oct 26 (Reuters) - Alligator Bioscience AB ::Q3 NET SALES SEK 0.2 MILLION VERSUS SEK 1.8 MILLION YEAR AGO.Q3 OPERATING LOSS SEK 39.9 MILLION VERSUS LOSS SEK 24.5 MILLION YEAR AGO.  Full Article

Alligator Bioscience Submits Application For ATOR-1015 Phase I Study
Thursday, 19 Jul 2018 

July 19 (Reuters) - ALLIGATOR BIOSCIENCE AB ::HAS SUBMITTED CLINICAL TRIAL AUTHORIZATION (CTA) APPLICATION TO START PHASE I STUDY OF DRUG CANDIDATE ATOR-1015.  Full Article

Alligator Bioscience Q2 Operating Loss Widens To SEK 39.1 Mln
Thursday, 12 Jul 2018 

July 12 (Reuters) - Alligator Bioscience AB ::APRIL-JUNE NET SALES, SEK 0.4 MILLION (1.3).APRIL-JUNE OPERATING RESULT, SEK -39.1 MILLION (-29.5).  Full Article

Alligator Bioscience Q1 Operating Loss Widens To SEK 44.0 Million
Thursday, 26 Apr 2018 

April 26 (Reuters) - ALLIGATOR BIOSCIENCE AB ::Q1 NET SALES SEK 776,000 VERSUS SEK 2.5 MILLION YEAR AGO.Q1 OPERATING LOSS SEK 44.0 MILLION VERSUS LOSS SEK 19.1 MILLION YEAR AGO.  Full Article

Alligator Bioscience Contracts Theradex Oncology As Clinical CRO
Thursday, 25 Jan 2018 

Jan 25 (Reuters) - ALLIGATOR BIOSCIENCE AB ::ALLIGATOR BIOSCIENCE CONTRACTS THERADEX ONCOLOGY AS CLINICAL CRO FOR THE UPCOMING ATOR-1015 PHASE I STUDY.STUDY IS EXPECTED TO COMMENCE IN SECOND HALF OF 2018.  Full Article

Alligator Bioscience To Receive Milestone Payment From Janssen
Wednesday, 3 Jan 2018 

Jan 3 (Reuters) - Alligator Bioscience Ab ::ALLIGATOR BIOSCIENCE TO RECEIVE USD 6 MILLION MILESTONE PAYMENT FROM JANSSEN COUPLED TO THE DECISION TO INITIATE COMBINATION TRIAL WITH ADC-1013.ELIGIBLE TO RECEIVE TIERED ROYALTIES ON WORLDWIDE NET SALES UPON SUCCESSFUL LAUNCH AND COMMERCIALIZATION.‍LICENSING AGREEMENT WITH JANSSEN BIOTECH ENCOMPASSES MILESTONE PAYMENTS UP TO A POTENTIAL OF USD 695 MILLION​.  Full Article

Alligator Bioscience appoints Charlotte A Russell as Chief Medical Officer​
Monday, 4 Dec 2017 

Dec 4 (Reuters) - ALLIGATOR BIOSCIENCE AB ::ALLIGATOR BIOSCIENCE AB - ‍APPOINTMENT OF CHARLOTTE A RUSSELL AS CHIEF MEDICAL OFFICER​.ALLIGATOR BIOSCIENCE AB - ‍RUSSELL WILL JOIN ALLIGATOR FROM HER ROLE AS SENIOR MEDICAL DIRECTOR AT GENMAB A/S​.  Full Article

Alligator Bioscience ‍Q3 operating loss widens to SEK 24.5 mln​
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - ALLIGATOR BIOSCIENCE AB :Q3 NET SALES, SEK 1.8 MILLION (4.7).‍Q3 OPERATING LOSS, SEK 24.5 MILLION (LOSS: 9.1)​.  Full Article